WNK2 and cancer: NE can activate the extracellular transactivation of membrane receptors such as epidermal growth factor receptor (EGFR) and Toll-like receptor 4 (TLR4), inducing mitogen activated protein kinase (MAPK) signaling and downstream effects, thereby directly promoting cancer cell proliferation.